MEI Pharma, Inc.
Isoflavonoid compositions and methods for the treatment of cancer
Last updated:
Abstract:
Provided herein is a pharmaceutical composition comprising an isoflavonoid derivative and a cyclodextrin. Also provided herein are methods of treating cancer, sensitizing cancer cells, and inducing apoptosis in cancer cells by administering such compositions. In specific instances, provided herein are intravenous compositions and therapies.
Status:
Grant
Type:
Utility
Filling date:
24 Apr 2018
Issue date:
6 Aug 2019